Local Sustained Delivery of 25-Hydroxyvitamin D3 for Production of Antimicrobial Peptides
- 431 Downloads
This study seeks to develop fiber membranes for local sustained delivery of 25-hydroxyvitamin D3 to induce the expression and secretion of LL-37 at or near the surgical site, which provides a novel therapeutic approach to minimize the risk of infections.
25-hydroxyvitamin D3 loaded poly(L-lactide) (PLA) and poly(ε-caprolactone) (PCL) fibers were produced by electrospinning. The morphology of obtained fibers was characterized using atomic force microscope (AFM) and scanning electron microscope (SEM). 25-hydroxyvitamin D3 releasing kinetics were quantified by enzyme-linked immunosorbent assay (ELISA) kit. The expression of cathelicidin (hCAP 18) and LL-37 was analyzed by immunofluorescence staining and ELISA kit. The antibacterial activity test was conducted by incubating pseudomonas aeruginosa in a monocytes’ lysis solution.
AFM images suggest that the surface of PCL fibers is smooth, however, the surface of PLA fibers is relatively rough, in particular, after encapsulation of 25-hydroxyvitamin D3. The duration of 25-hydroxyvitamin D3 release can last more than 4 weeks for all the tested samples. Plasma treatment can promote the release rate of 25-hydroxyvitamin D3. Human keratinocytes and monocytes express significantly higher levels of hCAP18/LL-37 after incubation with plasma treated and 25-hydroxyvitamin D3 loaded PCL fibers than the cells incubated with around ten times amount of free drug. After incubation with this fiber formulation for 5 days LL-37 in the lysis solutions of U937 cells can effectively kill the bacteria.
Plasma treated and 25-hydroxyvitamin D3 loaded PCL fibers induce significantly higher levels of antimicrobial peptide production in human keratinocytes and monocytes without producing cytotoxicity.
KEY WORDS25-hydroxyvitamin D3 electrospinning fibers local sustained delivery surgical site infection
Atomic force microscope
Dulbecco’s modified eagle medium
Enzyme-linked immunosorbent assay
Fetal bovine serum
U.S. Food and Drug Administration
Phosphate buffer solution
Roswell Park Memorial Institute
Scanning electron microscope
ACKNOWLEDGMENTS AND DISCLOSURES
This work was supported partially from startup funds from University of Nebraska Medical Center and National Institute of General Medical Science (NIGMS) grant 2P20 GM103480-06.
- 14.Pinzone MR, Di Rosa M, Celesia BM, Condorelli F, Malaguarnera M, Madeddu G, et al. LPS and HIV gp120 modulate monocyte/macrophage CYP27B1 and CYP24A1 expression leading to vitamin D consumption and hypovitaminosis D in HIV-infected individuals. Eur Rev Med Pharmacol Sci. 2013;17(14):1938–50.PubMedGoogle Scholar
- 29.Lin Xiao BW. Poly(Lactic Acid)-based biomaterials: synthesis, modification and applications. In: Dhanjoo NG, editor. Biomedical science, engineering and technology. Rijeka: Intech; 2012. p. 247–79.Google Scholar
- 50.Dumville JC, Gray TA, Walter CJ, Sharp CA, Page T. Dressings for the prevention of surgical site infection. Cochrane Database Syst Rev. 2011;6(7), CD003091.Google Scholar